-
Former CFTC Chair Says Self-Regulation Path Forward To Avoid Lengthy Litigation: 'Way To Get Investor Protection Standards'
Monday, July 10, 2023 - 11:44pm | 496Read More...Former chairman of the Commodity Futures Trading Commission (CFTC), Timothy Massad, on Monday, advocated for the creation of a self-regulatory organization (SRO) to oversee the cryptocurrency industry. What Happened: In an interview with CNBC’s Jim Cramer, Massad said the need for regulation...
-
Immunogen Shares Pop After Hours (IMGN)
Thursday, April 15, 2010 - 6:30pm | 94Read More...Shares of Immunogen (NASDAQ: IMGN) received a nice boost after hours due to the CEO's appearance on CNBC's Mad Money with Jim Cramer. The CEO of Immunogen told Cramer that the company's cancer drug, TDM-1, may be a $2-5 billion drug. The CEO also added the drug may be on the market as early as 2011...
